Stay updated on Nivolumab Plus Bevacizumab in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.

Latest updates to the Nivolumab Plus Bevacizumab in GBM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes the addition of the term 'Glioblastoma' and the study identifier 'CASE1317'. However, significant core content regarding the study's purpose, drug details, and participant criteria has been removed.SummaryDifference57%
- Check30 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed the date 2025-03-25 while adding the dates 2025-01-13 and 2025-02-28.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect the most recent results and revisions, with the estimated dates replaced by actual dates. The revision number has also been incremented.SummaryDifference0.3%
- Check66 days agoChange DetectedThe webpage has updated its date information, removing several past dates and adding new future dates for events or deadlines.SummaryDifference0.5%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
Stay in the know with updates to Nivolumab Plus Bevacizumab in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Bevacizumab in GBM Clinical Trial page.